Cerebral Venous Sinus Thrombosis (CVST) as a Complication of SARS-COV2 Infection

S. Pujari, Pawan K. Ojha, R. Kulkarni, Dr Sumit Kharat, Dulari Gupta, R. Lalla, Keyur Panchal, P. Walzade, Nilesh Palasdeokar, D. Nadgir, S. Nirhale, Pramod Dhonde, N. Ichaporia, Sujit A. Jagtap, A. Dravid, B. Purandare, S. Jog, Z. Khan, C. Meshram
{"title":"Cerebral Venous Sinus Thrombosis (CVST) as a Complication of SARS-COV2 Infection","authors":"S. Pujari, Pawan K. Ojha, R. Kulkarni, Dr Sumit Kharat, Dulari Gupta, R. Lalla, Keyur Panchal, P. Walzade, Nilesh Palasdeokar, D. Nadgir, S. Nirhale, Pramod Dhonde, N. Ichaporia, Sujit A. Jagtap, A. Dravid, B. Purandare, S. Jog, Z. Khan, C. Meshram","doi":"10.1177/25166085221089731","DOIUrl":null,"url":null,"abstract":"Background and Purpose: Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) infection induces a prothrombotic state frequently associated with arterial ischemic strokes. Cerebral venous sinus thrombosis (CVST) is also reported with corona virus disease-19 (COVID-19) but a large cohort study is lacking. Our aim was to study the characteristics, treatment response, and outcomes of CVST occurring in association with COVID-19 (COVID-CVST) and the causal relationship with COVID-19. Methods: Data of 34 patients admitted in COVID facility and suffering from CVST and SARS-COV2 infection was studied with respect to their clinic-radiological and lab features, predisposing factors, treatment, and outcome. Observations and Results: 15 patients with CVST were detected positive for COVID but remained asymptomatic for the same. 14 patients had CVST along with symptoms of COVID, whereas 5 had CVST after recovery from COVID, at an average of 18 days after COVID-19. 4 patients were on aspirin as prophylaxis against thrombo-embolic events. The number of males exceeded females (22:12), conventional risk factors were seen in only 8 patients (postpartum state-3, alcohol abuse-2 and anemia-3), whereas the majority (26/34) showed none of them. The mean serum homocysteine level was normal and antiphospholipid antibody was tested normal in the assessed subjects. D-dimer and C reactive protein were elevated in all. 4 symptomatic patients who suffered from severe pneumonia died because of systemic complications. Conclusion: COVID-19 predisposes to CVST and the outcome is related to the severity of COVID pneumonia. CVST related to COVID occurs during or after a few weeks of COVID pneumonia and can also be seen in asymptomatic SARS-COV2 infection. COVID-19 can occur independently or in association with traditional thrombotic risk factors which increase the risk and severity of CVST in COVID. If recognized early, CVST associated with COVID can usually be treated effectively to achieve a very good outcome.","PeriodicalId":93323,"journal":{"name":"Journal of stroke medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of stroke medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25166085221089731","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Purpose: Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) infection induces a prothrombotic state frequently associated with arterial ischemic strokes. Cerebral venous sinus thrombosis (CVST) is also reported with corona virus disease-19 (COVID-19) but a large cohort study is lacking. Our aim was to study the characteristics, treatment response, and outcomes of CVST occurring in association with COVID-19 (COVID-CVST) and the causal relationship with COVID-19. Methods: Data of 34 patients admitted in COVID facility and suffering from CVST and SARS-COV2 infection was studied with respect to their clinic-radiological and lab features, predisposing factors, treatment, and outcome. Observations and Results: 15 patients with CVST were detected positive for COVID but remained asymptomatic for the same. 14 patients had CVST along with symptoms of COVID, whereas 5 had CVST after recovery from COVID, at an average of 18 days after COVID-19. 4 patients were on aspirin as prophylaxis against thrombo-embolic events. The number of males exceeded females (22:12), conventional risk factors were seen in only 8 patients (postpartum state-3, alcohol abuse-2 and anemia-3), whereas the majority (26/34) showed none of them. The mean serum homocysteine level was normal and antiphospholipid antibody was tested normal in the assessed subjects. D-dimer and C reactive protein were elevated in all. 4 symptomatic patients who suffered from severe pneumonia died because of systemic complications. Conclusion: COVID-19 predisposes to CVST and the outcome is related to the severity of COVID pneumonia. CVST related to COVID occurs during or after a few weeks of COVID pneumonia and can also be seen in asymptomatic SARS-COV2 infection. COVID-19 can occur independently or in association with traditional thrombotic risk factors which increase the risk and severity of CVST in COVID. If recognized early, CVST associated with COVID can usually be treated effectively to achieve a very good outcome.
脑静脉窦血栓(CVST)是SARS-COV2感染的并发症
背景和目的:严重急性呼吸综合征冠状病毒2 (SARS-COV2)感染可诱导血栓前状态,通常与动脉缺血性中风相关。脑静脉窦血栓形成(CVST)也报道与冠状病毒病-19 (COVID-19),但缺乏大型队列研究。我们的目的是研究与COVID-19相关的CVST (COVID-CVST)的特征、治疗反应和结局,以及与COVID-19的因果关系。方法:对收治的34例CVST合并SARS-COV2感染患者的临床影像学和实验室特征、易感因素、治疗方法和转归进行分析。观察与结果:15例CVST患者检出COVID阳性,但无症状。14例患者出现CVST并伴有新冠肺炎症状,而5例患者在新冠肺炎后平均18天恢复后出现CVST。4例患者服用阿司匹林预防血栓栓塞事件。男性多于女性(22:12),仅有8例患者存在常规危险因素(产后状态3、酗酒-2和贫血-3),绝大多数(26/34)患者不存在常规危险因素。研究对象平均血清同型半胱氨酸水平正常,抗磷脂抗体检测正常。d -二聚体和C反应蛋白均升高。4例有症状的重症肺炎患者因全身性并发症死亡。结论:COVID-19易致CVST,其结局与COVID-19肺炎的严重程度有关。与COVID相关的CVST发生在COVID肺炎期间或几周之后,也可在无症状的SARS-COV2感染中看到。COVID-19可独立发生,也可与增加COVID中CVST风险和严重程度的传统血栓形成危险因素相关。如果及早发现,与COVID相关的CVST通常可以得到有效治疗,达到非常好的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信